Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C017229 |
1,2-dihydro-1,2-dihydroxy-5-methylchrysene |
UGT2A1 protein results in increased glucuronidation of 1,2-dihydro-1,2-dihydroxy-5-methylchrysene | increases glucuronidation | 21164388
|
C032136 |
1-hydroxybenzo(a)pyrene |
UGT2A1 protein results in increased glucuronidation of 1-hydroxybenzo(a)pyrene | increases glucuronidation | 21164388
|
C033146 |
1-hydroxypyrene |
UGT2A1 protein results in increased glucuronidation of 1-hydroxypyrene | increases glucuronidation | 21164388
|
C029350 |
1-naphthol |
UGT2A1 protein results in increased glucuronidation of 1-naphthol | increases glucuronidation | 21164388
|
C021338 |
3-hydroxybenzo(a)pyrene |
UGT2A1 protein results in increased glucuronidation of 3-hydroxybenzo(a)pyrene | increases glucuronidation | 21164388
|
C489431 |
4-methylumbelliferone |
UGT2A1 protein results in increased glucuronidation of 4-methylumbelliferone | increases glucuronidation | 21164388
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of UGT2A1 mRNA | affects expression | 17562736
|
C040534 |
alpha-hexachlorocyclohexane |
alpha-hexachlorocyclohexane results in increased expression of UGT2A1 mRNA | increases expression | 16940010
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of UGT2A1 mRNA | affects expression | 16483693
|
C017228 |
benzo(a)pyrene 7,8-dihydrodiol |
UGT2A1 protein results in increased glucuronidation of benzo(a)pyrene 7,8-dihydrodiol | increases glucuronidation | 21164388
|
D001564 |
Benzo(a)pyrene |
UGT2A1 protein results in increased glucuronidation of Benzo(a)pyrene analog | increases glucuronidation | 21164388
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2A1 mRNA | affects cotreatment|affects expression | 17602206
|
D003907 |
Dexamethasone |
Dexamethasone affects the expression of UGT2A1 mRNA | affects expression | 15102944
|
C071371 |
dibenzo(a,l)pyrene 11,12-dihydrodiol |
UGT2A1 protein results in increased glucuronidation of dibenzo(a,l)pyrene 11,12-dihydrodiol | increases glucuronidation | 21164388
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2A1 mRNA | affects cotreatment|affects expression | 17602206
|
C099406 |
L 742694 |
L 742694 affects the expression of UGT2A1 mRNA | affects expression | 15102944
|
D011084 |
Polycyclic Hydrocarbons, Aromatic |
UGT2A1 protein affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 21164388
|
C025299 |
polyphenols |
polyphenols results in decreased expression of UGT2A1 mRNA | decreases expression | 16293270
|
C045950 |
propiconazole |
propiconazole results in increased expression of UGT2A1 mRNA | increases expression | 19423681
|
C446685 |
systhane |
systhane results in increased expression of UGT2A1 mRNA | increases expression | 19423681
|
C032910 |
triadimefon |
triadimefon results in increased expression of UGT2A1 mRNA | increases expression | 19423681
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.96 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.42 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.42 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.79 | 17162532 16434500 18056438 19052882 19061943 17620307 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.74 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.96 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
3.47 | 17659584 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.11 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.11 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.80 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
2.80 | 16807293 19519916 19394651 20512989 20007298 17761372 16779866 18665156 20524982 19208518 11831363 16681979 17428255 19539802 20935162 18788625 17138121 18393292 19335982 17055752 17173139 20101231 20084675 16698587 21159647 10672840 16288022 20432363 19822196 16502159 3581430 10737359 18506893 19052882 19171122 19418558 17978847 18056438 18785209 16830150 17162532 18494052 18978308 16878318 3084413 16540662 16569478 20727157 20514400 18691550 19383236 18971187 18210153 19919837 20214788 19107877 19701751 16935385 16328049 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.02 | 20419170 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.52 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.78 | 17174075 21159647 2727394 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.59 | 19052882 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
3.68 | 16781842 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
4.02 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
4.02 | 16293270 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
3.18 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
3.18 | 16875885 15834900 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.30 | 12438553 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.16 | 20387270 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.59 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.10 | 11421492 2444490 15619225 19923254 15968718 12392966 16109766 16781746 19420014 19416960 19085960 11287661 14986274 10663392 16227642 11529661 16177239 16081117 17522070 16485898 12958197 11743745 10774834 19739265 11834606 18713872 10915739 17562736 17906064 19370779 12705907 14725611 14550746 19164858 12594235 12540782 18071297 12153990 16393943 11461765 11739529 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.10 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.10 | 19370779 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.99 | 19426721 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.35 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
3.31 | 19703484 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.01 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.98 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.09 | 20387270 21071580 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.57 | 16983495 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.60 | 20471113 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
14.35 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
14.35 | 17178688 17178689 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
14.35 | 17178688 17178689 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.03 | 7520565 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.61 | 16870215 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
2.89 | 17042910 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
8.17 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.17 | 18785209 |
MESH:D007249 |
Inflammation |
|
polyphenols |
8.17 | 16366677 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
4.86 | 15834900 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.14 | 12587719 15629191 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.76 | 18522880 19638242 18407596 20032147 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
2.26 | 16718785 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
12.27 | 16610002 12969438 19014921 12587719 16611625 11587558 19460945 19784758 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
12.27 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
12.27 | 16698588 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
12.27 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
12.27 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.14 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.85 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
13.85 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
13.85 | 2862719 21047994 19850985 19833225 19254457 19073162 10737359 9163691 19090486 19427195 19642983 12112319 20434301 20137499 15885732 19256749 20501860 21278145 19996281 19499222 15175105 16942905 20405173 19638242 19812893 12771043 20583210 20452335 21167192 19551842 2422723 21071580 18754104 18648771 18977376 20101389 20118626 18978307 18644402 19426721 19255062 19294768 20492335 19690152 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
13.85 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
13.85 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.75 | 17942915 19009564 3124819 18544905 19126423 21159647 18093689 19004024 18164116 18079962 18253720 2563599 18775883 18308698 19539802 17174075 9362446 18282651 17854601 19519916 16267830 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
13.75 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
13.75 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
13.75 | 17178689 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.85 | 17053015 20464547 20135361 18520028 20064080 18816296 6695378 18569708 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
4.85 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.85 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Polycyclic Hydrocarbons, Aromatic |
4.85 | 10814675 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.46 | 19513568 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.10 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.43 | 15744524 16118317 15867202 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.48 | 9809623 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.52 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.12 | 11141357 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.88 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.88 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.01 | 20387270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.30 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.38 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.46 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.48 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.00 | 17292933 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.91 | 11700416 18379247 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.32 | 10029692 19755658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.21 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.30 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.39 | 15138204 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.15 | 17997062 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.28 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
7.28 | 17178689 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.14 | 17053015 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.87 | 10982225 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.71 | 1336536 |